ChEMBL ID: CHEMBL4297794
Mechanism of action: Interleukin-31 receptor subunit alpha inhibitor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to NEMOLIZUMAB